Latest news
Explore more
ErVimmune raises €17M to advance first cancer vaccine into clinical trials
The round was backed by Seventure Partners, SPRIM Global Investments, and supported by Bpifrance and France 2030.
Oviva raises €200M series D to expand AI-enabled chronic care across Europe
The round saw support from Kinnevik, Planet First Partners, A.P. Moller Holding, Lunate, EGS Beteiligungen, Norrsken VC, and existing backer Sofina.
Czech-founded Mews raises $300M at $2.5B valuation to accelerate the AI future of hospitality
The Series D round was led by EQT Growth, with participation from new investors Atomico and HarbourVest Partners, alongside existing backers Kinnevik, Battery Ventures and Tiger Global.